Mr. Christopher Scott King, CADC INTERN Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 20 Isabella Dr, Manchester, NJ 08759 Phone: 908-644-2604 |
Tynisha Clarke Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 149 10th Ave, Manchester, NJ 08759 Phone: 732-575-6770 |
Ms. Tiffany Hauptman, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 468a Chelsea Ct, Manchester, NJ 08759 Phone: 732-850-8434 |
Ms. Diana L Allen, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1 Maidstone Way, Manchester, NJ 08759 Phone: 973-943-2742 |
Rachel Melissa Perlman, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 280 Lindbergh Sq, Manchester, NJ 08759 Phone: 732-930-3321 |
Martina Lambiase, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 59a Cambridge Cir, Manchester, NJ 08759 Phone: 908-246-3866 |
News Archive
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the presence and integrity of the opioid growth factor receptor (OGFr), which mediates the inhibitory action of opioid growth factor (OGF) on cell proliferation, is a key to understanding the progression and treatment of human ovarian cancer.
In this post on her blog, "The Garrett Update" - the last of a series of posts examining the safety of drugs and vaccines - Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), further details the key findings of the CFR's Policy Innovation Memorandum No. 21, a six-point policy recommendation for the G8/20 that she authored, titled "Ensuring the Safety and Integrity of the World's Drug, Vaccine, and Medicines Supply."
New techniques for detecting emboli (harmful blood clots/air bubbles in arteries) developed at the University of Leicester have played a major role in dramatically reducing stroke rates after carotid endarterectomy.
ThromboGenics NV has announced that it has completed a global license agreement with Millipore Corporation under which ThromboGenics will exclusively license its technology for production of the proprietary stem cell culture medium marketed by Millipore as RESGRO(x).
A portable, finger-probe device successfully measured liver function in brain dead adult organ donors, a finding that could change the way organs are assessed and save thousands of dollars per transplant, a UCLA study has found.
› Verified 5 days ago